Literature DB >> 3651512

Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages.

J T Derksen1, H W Morselt, G L Scherphof.   

Abstract

We compared the metabolic fate of [3H]cholesteryl[14C]oleate, [3H]cholesteryl hexadecylether, 125I-labeled bovine serum albumin and [3H]inulin as constituents of large immunoglobulin-coupled unilamellar lipid vesicles following their internalization by rat liver macrophages (Kupffer cells) in monolayer culture. Under serum-free conditions, the cholesteryl oleate that is taken up is hydrolyzed, for the greater part, within 2 h. This occurs in the lysosomal compartment as judged by the inhibitory effect of the lysosomotropic agents monensin and chloroquin. After hydrolysis, the cholesterol moiety is accommodated in the cellular pool of free cholesterol and the oleate is reutilized for the synthesis mainly of phospholipids and, to a lesser extent of triacylglycerols. During incubation in plasma, however, substantial proportions of both the cholesterol and the oleate are shed from the cells, predominantly in the unesterified form. When the liposomes are labeled with the cholesteryl ester analog [3H]cholesteryl hexadecylether only a very small fraction of the label is released from the cells, even in the presence of plasma. Similar to the label remaining associated with the cells, the released label is identified in that case as unchanged cholesteryl ether. The liposomal aqueous phase marker 125I-labeled bovine serum albumin is also readily degraded intralysosomally and the radioactive label is rapidly released from the cells in a trichloroacetic acid-soluble form. Also, as much as 20% of the aqueous phase marker [3H]inulin that becomes cell-associated during a 2-h incubation with inulin-containing liposomes, is released from the cells during a subsequent 4-h incubation period in medium or rat plasma. The usefulness of the various liposomal labels as parameters of liposome uptake and intracellular processing is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651512     DOI: 10.1016/0167-4889(87)90047-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism.

Authors:  H Harashima; S Komatsu; S Kojima; C Yanagi; Y Morioka; M Naito; H Kiwada
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

2.  A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model.

Authors:  Sebastian Cogswell; Stuart Berger; Dawn Waterhouse; Marcel B Bally; Ellen K Wasan
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

3.  Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4).

Authors:  Stephan Holzschuh; Kathrin Kaeß; Alfred Fahr; Christiane Decker
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

4.  Phagocytosis of liposomes by human platelets.

Authors:  R Male; W E Vannier; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

5.  Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces.

Authors:  Keita Kaneko; Kohei Togami; Eri Yamamoto; Shujun Wang; Kazuhiro Morimoto; Shirou Itagaki; Sumio Chono
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

6.  Liposomal cholesterol delivery activates the macrophage innate immune arm to facilitate intracellular Leishmania donovani killing.

Authors:  June Ghosh; Rajan Guha; Shantanabha Das; Syamal Roy
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

7.  The use of radioactive marker as a tool to evaluate the drug release in plasma and particle biodistribution of block copolymer nanoparticles.

Authors:  Sharon Johnstone; Steven Ansell; Sherwin Xie; Lawrence Mayer; Paul Tardi
Journal:  J Drug Deliv       Date:  2011-07-07

8.  Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.

Authors:  Kent T J Chen; Malathi Anantha; Ada W Y Leung; Jayesh A Kulkarni; Gardenia G C Militao; Mohamed Wehbe; Brent Sutherland; Pieter R Cullis; Marcel B Bally
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

9.  Comparison of Polysaccharides as Coatings for Quercetin-Loaded Liposomes (QLL) and Their Effect as Antioxidants on Radical Scavenging Activity.

Authors:  Manuel Román-Aguirre; César Leyva-Porras; Pedro Cruz-Alcantar; Alfredo Aguilar-Elguézabal; María Zenaida Saavedra-Leos
Journal:  Polymers (Basel)       Date:  2020-11-26       Impact factor: 4.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.